Macrolide Therapy
Macrolide Therapy is a form of antibacterial therapy that utilizes macrolide antibiotics—bacteriostatic agents that inhibit protein synthesis by binding to the 50S ribosomal subunit—to target gram-positive and atypical pathogens, distinguished by its unique polyketide lactone ring structure and favorable intracellular penetration.
1K
Publications
63.1K
Citations
5.2K
Authors
1.5K
Institutions
Publications per year
2017–2026
165
Parents
1K
Helena Seppälä, Timo Klaukka, Jaana Vuopio‐Varkila et al. · New England Journal of Medicine · 1997 · 1.2K citations · Full text
Azithromycin for Prevention of Exacerbations of COPD
Richard Albert, John E. Connett, William C. Bailey et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text
1–5 of 1K
5.2K
11
h-index
10
h-index
Cempra Pharmaceuticals (United States), United States
10 publications · 790 citations
10
h-index
Penn State Milton S. Hershey Medical Center, United States
11 publications · 701 citations
10
h-index
9
h-index
1–5 of 5.2K
1.5K
Sungkyunkwan University
Seoul, South Korea
16 h-index
104 publications
6.5K citations

Nagasaki University
Nagasaki, Japan
16 h-index
82 publications
3.9K citations
Kitasato University
Tokyo, Japan
15 h-index
67 publications
4.8K citations

University of Colorado Denver
Denver, United States
15 h-index
25 publications
3.7K citations
Pfizer (United States)
New York, United States
14 h-index
109 publications
13.6K citations
University of Illinois Chicago
Chicago, United States
13 h-index
40 publications
3K citations
Abbott Fund
Chicago, United States
12 h-index
58 publications
4.4K citations
Samsung Medical Center
Seoul, South Korea
11 h-index
81 publications
5.3K citations
1–8 of 1.5K
AAC · 116 publications · 9.3K citations
56
h-index
JAC · 49 publications · 2.7K citations
31
h-index
Repository · 72 publications · 2.7K citations
29
h-index
40 publications · 1.1K citations
20
h-index
CID · 21 publications · 2K citations
18
h-index
1–5